These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28945875)

  • 21. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
    Holzner B; Efficace F; Basso U; Johnson CD; Aaronson NK; Arraras JI; Smith AB; Chow E; Oberguggenberger AS; Bottomley A; Steiner H; Incrocci L; Giesinger JM
    Qual Life Res; 2013 Mar; 22(2):369-78. PubMed ID: 22407356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
    Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
    J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
    Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
    Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
    Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
    Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III.
    Singer S; Araújo C; Arraras JI; Baumann I; Boehm A; Brokstad Herlofson B; Castro Silva J; Chie WC; Fisher S; Guntinas-Lichius O; Hammerlid E; Irarrázaval ME; Jensen Hjermstad M; Jensen K; Kiyota N; Licitra L; Nicolatou-Galitis O; Pinto M; Santos M; Schmalz C; Sherman AC; Tomaszewska IM; Verdonck de Leeuw I; Yarom N; Zotti P; Hofmeister D;
    Head Neck; 2015 Sep; 37(9):1358-67. PubMed ID: 24832623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module.
    Nowak AK; Stockler MR; Byrne MJ
    J Clin Oncol; 2004 Aug; 22(15):3172-80. PubMed ID: 15284270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early development phases of a European Organisation for Research and Treatment of Cancer (EORTC) module to assess patient reported outcomes (PROs) in women undergoing breast reconstruction.
    Thomson HJ; Winters ZE; Brandberg Y; Didier F; Blazeby JM; Mills J
    Eur J Cancer; 2013 Mar; 49(5):1018-26. PubMed ID: 23063353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
    Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
    Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
    Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer.
    Viada C; Bouza C; Fors M; Frías A; Alvarez M; García L; Wilkinson B; Rodríguez C; Crombet T; Ballesteros J
    Qual Life Res; 2020 Dec; 29(12):3441-3448. PubMed ID: 33136243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
    Whistance RN; Conroy T; Chie W; Costantini A; Sezer O; Koller M; Johnson CD; Pilkington SA; Arraras J; Ben-Josef E; Pullyblank AM; Fayers P; Blazeby JM;
    Eur J Cancer; 2009 Nov; 45(17):3017-26. PubMed ID: 19765978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting.
    Nicklasson M; Bergman B
    Qual Life Res; 2007 Aug; 16(6):1019-28. PubMed ID: 17479356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of instruments for measuring quality of life in patients with lung cancer.
    Hollen PJ; Gralla RJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):31-40. PubMed ID: 8610235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.
    Koller M; Warncke S; Hjermstad MJ; Arraras J; Pompili C; Harle A; Johnson CD; Chie WC; Schulz C; Zeman F; van Meerbeeck JP; Kuliś D; Bottomley A; ;
    Cancer; 2015 Dec; 121(24):4300-23. PubMed ID: 26451520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
    Maringwa JT; Quinten C; King M; Ringash J; Osoba D; Coens C; Martinelli F; Vercauteren J; Cleeland CS; Flechtner H; Gotay C; Greimel E; Taphoorn MJ; Reeve BB; Koch JS; Weis J; Smit EF; van Meerbeeck JP; Bottomley A;
    Support Care Cancer; 2011 Nov; 19(11):1753-60. PubMed ID: 20886240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.